etravirine has been researched along with sitagliptin in 2 studies
| Studies (etravirine) | Trials (etravirine) | Recent Studies (post-2010) (etravirine) | Studies (sitagliptin) | Trials (sitagliptin) | Recent Studies (post-2010) (sitagliptin) |
|---|---|---|---|---|---|
| 572 | 90 | 321 | 97 | 0 | 70 |
| Protein | Taxonomy | etravirine (IC50) | sitagliptin (IC50) |
|---|---|---|---|
| Chain A, Dipeptidyl peptidase IV | Homo sapiens (human) | 0.018 | |
| Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | 0.0255 | |
| Thromboxane-A synthase | Homo sapiens (human) | 0.0194 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.0236 | |
| Dipeptidyl peptidase 4 | Mus musculus (house mouse) | 0.046 | |
| Prolyl endopeptidase FAP | Homo sapiens (human) | 2.93 | |
| Dipeptidyl peptidase 8 | Homo sapiens (human) | 0.4715 | |
| Dipeptidyl peptidase 9 | Homo sapiens (human) | 1.539 | |
| Dipeptidyl peptidase 2 | Homo sapiens (human) | 0.022 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for etravirine and sitagliptin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for etravirine and sitagliptin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |